Johnson & Johnson (JNJ)

141.04
0.66 0.47
NYSE : Health Technology
Prev Close 140.38
Open 141.25
Day Low/High 140.33 / 141.84
52 Wk Low/High 109.16 / 157.00
Volume 1.91M
Avg Volume 8.62M
Exchange NYSE
Shares Outstanding 2.63B
Market Cap 370.50B
EPS 5.70
P/E Ratio 21.94
Div & Yield 4.04 (2.78%)
I Wouldn't Buy Pfizer Shares on This Pop

I Wouldn't Buy Pfizer Shares on This Pop

I would wait until the next down day, and there will be one.

Jim Cramer: Is the Day Where the Virus Ruled Our Lives Waning?

Jim Cramer: Is the Day Where the Virus Ruled Our Lives Waning?

That's the really good news about why we could bounce back so quickly from Thursday's debacle.

Warp Speed for 5 Vaccine Candidates, Watching KLA Corp, Trading Thoughts

Warp Speed for 5 Vaccine Candidates, Watching KLA Corp, Trading Thoughts

The administration will provide increased financial support to 5 pharmas working on Covid vaccines, and we must keep an eye on price action in this uncertain market.

Jim Cramer: What's Normalcy in This Country?

Jim Cramer: What's Normalcy in This Country?

We're cheering what may be an aberration, a bullish employment number. We'll take what it brings - a wholesale shift in what we're buying and what we're selling to fund it.

Jim Cramer: This Is a Brave New Economy We're In

Jim Cramer: This Is a Brave New Economy We're In

The Fed and Treasury are set on avoiding the mistakes that doomed us in the past, and we have to invest for this new market we're in now.

China Headline Risk, Valuation Station and a Workday Play

China Headline Risk, Valuation Station and a Workday Play

WDAY looks ready to break out as traders weigh wether markets are now overbought after this 2-day run.

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.

Merck Is All In With a Threefold Approach to Covid-19

Merck Is All In With a Threefold Approach to Covid-19

I've been long Merck for a long time, since way before this pandemic became part of our lives.

Floor Traders Return to NYSE, Novavax Vaccine News, Be Amphibious

Floor Traders Return to NYSE, Novavax Vaccine News, Be Amphibious

The return of NYSE floor traders is symbolic of the return to normalcy, as vaccine candidate manufacturers are scaling up for mass production.

Jim Cramer: It's Still Better to Be Safe Than Sorry

Jim Cramer: It's Still Better to Be Safe Than Sorry

Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.

Moderna Is a Breath of Fresh Air

Moderna Is a Breath of Fresh Air

I'm long this name, as I am several of the others involved. Will I add on a day like this?

Powell's Reassurance, Nvidia's Breakout Higher, Trading Thoughts

Powell's Reassurance, Nvidia's Breakout Higher, Trading Thoughts

Jerome Powell hit the airwaves with some words of caution and comfort. Nvidia is running into earnings.

Johnson & Johnson Is Pulling Back to Retest its Breakout Zone

Johnson & Johnson Is Pulling Back to Retest its Breakout Zone

The broad market may be soft for another week but if I find more stocks in a similar position as JNJ I won't see a reason to join the bear camp.

Sell Signals, 'Operation Warp Speed,' Trading Notes

Sell Signals, 'Operation Warp Speed,' Trading Notes

Trump administration taps former GlaxoSmithKline exec as head of vaccine task force, and how I'm playing Walmart and Datadog.

Jim Cramer: Let the Froth Wash Out

Jim Cramer: Let the Froth Wash Out

Let's look at the stocks that will get crushed and that you can't touch right now.

The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance

The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance

I have always liked the aggressive management.

Are You a Trader, Investor, or Opportunist?

Are You a Trader, Investor, or Opportunist?

Don't pigeon hole yourself into a certain pattern of action when you see opportunities.

Want to Know Why I'm Not Selling Moderna?

Want to Know Why I'm Not Selling Moderna?

I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.

This Chart Pattern Hints at a Bullish Future

This Chart Pattern Hints at a Bullish Future

The bullish reversal pattern is appearing not just in single names, but also in whole sectors.

Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine

Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine

PFE is collaborating with German drugmaker BioNTech in the effort to find a well tolerated, effective vaccine.

Earnings in Full Swing, Workplace Evolution, Fed Day

Earnings in Full Swing, Workplace Evolution, Fed Day

There was a mild increase in trading volume at the New York Stock Exchange, but it was a rotational shift.

Jim Cramer: Reopening Is Necessary, but Based on Little More Than Hope

Jim Cramer: Reopening Is Necessary, but Based on Little More Than Hope

It's imperative that people get back to work, so we have this great compromise -- let's see how it might play out.

Johnson & Johnson Cut to Neutral at UBS

Jim Cramer: CEOs Better Come Out Jacked on Their Conference Calls

Jim Cramer: CEOs Better Come Out Jacked on Their Conference Calls

Stop apologizing, don't surrender to the gloom and tell your story with sympathy but with glory, and don't make us feel like it's a mistake to own shares in your company.

Mid-Caps Outperform, Funding 'Paycheck Protection', U.K. Vaccine Trials

Mid-Caps Outperform, Funding 'Paycheck Protection', U.K. Vaccine Trials

Trading volumes dropping on major indexes, U.K. teams begin human trials on a Covid-19 vaccine, and the U.S. Senate wants another stimulus package addition.

Jim Cramer: How to Stay Safe, Until Quick Testing for Covid-19 Is Available

Jim Cramer: How to Stay Safe, Until Quick Testing for Covid-19 Is Available

Welcome to the new era. Social distancing is not without risks, but it is as good as it gets.

Futures Pop, Gilead's Covid-19 Treatment, Trading My 'Virus Group'

Futures Pop, Gilead's Covid-19 Treatment, Trading My 'Virus Group'

The rise in equity futures pricing was born of optimism from the president's task force draft guideline on reopening parts of the U.S. economy and Gilead Sciences' somewhat positive results on its remdisivir anti-viral treatment.

My New Multi-Group Portfolio Strategy for Trading the Pandemic

My New Multi-Group Portfolio Strategy for Trading the Pandemic

How has my book evolved since the Fed and Treasury rode into town? Here's how.

5 Ways to Invest in Testing, Vaccines and Clinical Trials

5 Ways to Invest in Testing, Vaccines and Clinical Trials

These companies have the potential to help in battling the Covid-19 pandemic.

Jim Cramer: I Don't Think Covid-19 Is Invincible

Jim Cramer: I Don't Think Covid-19 Is Invincible

When it's beaten you will wish you own stocks, especially the stocks that are right now lethal to your portfolio.